Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.
about
Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans.Shigella Vaccine Development: Finding the Path of Least Resistance.Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study.An update on vaccines against Shigella.Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypesSafety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.Human immune responses against Shigella and enterotoxigenic E. coli: Current advances and the path forward.A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccinThree-dimensional electron microscopy reconstruction and cysteine-mediated crosslinking provide a model of the type III secretion system needle tip complex.A clinically parameterized mathematical model of Shigella immunity to inform vaccine design.Transcriptomics in Human Challenge Models.T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans.
P2860
Q34068059-495B796C-AA0D-407F-9AAD-AD109DB89F27Q37477191-DD8596D8-4360-4ADC-AE30-B166C1404EABQ37633069-71965642-7CF7-4ACE-B199-F490D6C76CEEQ37668395-E514BAE6-35BD-433B-8557-F36DDB87023AQ37720658-A8E846DB-4888-4B1C-926A-314AF7C4867EQ38665950-0D859702-FF8B-4751-AAEC-1604BDB726A9Q38776163-CF192408-C42E-4D02-A344-C9483DEC925AQ40192692-49807225-035E-4A55-94A6-66DE5C8C2F30Q41986831-94CD2EB9-D370-4775-9EEC-907907B7E82EQ42566246-D71913F8-C030-4C7C-AF64-FBD8C14D74C6Q47205506-70F9867F-E6D9-4BB5-81A6-D0242BF124C8Q47400686-9A851F65-B20E-4DD8-A46F-61E2574F6793Q52657631-A2130947-AA26-4438-9E5A-D01DD046F5BA
P2860
Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Shigella antigen-specific B me ...... ild-type Shigella flexneri 2a.
@en
type
label
Shigella antigen-specific B me ...... ild-type Shigella flexneri 2a.
@en
prefLabel
Shigella antigen-specific B me ...... ild-type Shigella flexneri 2a.
@en
P2093
P2860
P1433
P1476
Shigella antigen-specific B me ...... ild-type Shigella flexneri 2a.
@en
P2093
Jakub K Simon
Marcelo B Sztein
Rezwanul Wahid
Wendy L Picking
P2860
P356
10.1016/J.CLIM.2013.03.009
P577
2013-03-26T00:00:00Z